EUVIMEDEUVIMED entdecken
Crossref

Mechanism of Bile‐Processed Coptidis Rhizoma in the Treatment of Type 2 Diabetes Mellitus in Rats Based on Dissolution Kinetics and Untargeted Metabolomics

Ying Zhu, Zhaowei Dong, Lu Yang, Qinwan Huang iD, Jin Wang

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Ying Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Diabetes Mellitus, Type 2, Metabolome, Bile. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bile‐processed Coptidis Rhizoma (BPCR) exhibits stronger efficacy in treating T2DM than Coptidis Rhizoma(CR) alone. However, the synergistic mechanism of its processing remains unknown. This study utilized HPLC to determine the content and dissolution characteristics of alkaloid components in BPCR before and after processing. The results indicated that the diffusion of the alkaloids in BPCR is stronger than that of CR, and their dissolution conforms to the Weibull equation. Additionally, BPCR significantly reduced fasting blood glucose (FBG) and serum insulin (FINS) levels in T2DM rats induced by a high‐fat diet (HFD) and streptozotocin (STZ), improved glucose and lipid metabolism, and mitigated liver damage. Serum metabolomics analysis based on UPLC‐Q‐TOF‐MS revealed that BPCR significantly regulates 27 endogenous differential biomarkers. The underlying mechanism may be related to glycerophospholipid metabolism, linoleic acid metabolism, steroid biosynthesis, and arachidonic acid metabolism pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalDiabetes Mellitus, Type 2MetabolomeBileHypoglycemic AgentsAnimalsRatsMetabolomicsMaleRats, Sprague-DawleyChromatography, High Pressure LiquidDiabetes Mellitus, ExperimentalBlood GlucoseAlkaloidsBiomarkersDiet, High-FatCoptis chinensis

Stichwörter der Autor:innen

alkaloidsbile‐processed Coptidis Rhizomadissolution kineticsglycolipid metabolismmetabolomicstype 2 diabetes

Substanzen

Drugs, Chinese HerbalCoptidis rhizoma extractBlood GlucoseAlkaloidsHypoglycemic AgentsBiomarkers

Autor:innen und Institutionen

  • College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • College of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

ORCID-Profile: Qinwan Huang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhu, Y., Dong, Z., Yang, L., Huang, Q., & Wang, J. (2025). Mechanism of Bile‐Processed Coptidis Rhizoma in the Treatment of Type 2 Diabetes Mellitus in Rats Based on Dissolution Kinetics and Untargeted Metabolomics. Biomedical Chromatography. https://doi.org/10.1002/bmc.70040

Vancouver

Zhu Y, Dong Z, Yang L, Huang Q, Wang J. Mechanism of Bile‐Processed Coptidis Rhizoma in the Treatment of Type 2 Diabetes Mellitus in Rats Based on Dissolution Kinetics and Untargeted Metabolomics. Biomedical Chromatography. 2025. doi:10.1002/bmc.70040

BibTeX
@article{Zhu2025,
  author = {Zhu, Ying and Dong, Zhaowei and Yang, Lu and Huang, Qinwan and Wang, Jin},
  title = {Mechanism of Bile‐Processed Coptidis Rhizoma in the Treatment of Type 2 Diabetes Mellitus in Rats Based on Dissolution Kinetics and Untargeted Metabolomics},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70040}
}
Kostenlos starten →